Priya Mistry1, Rebecca Heather Smith2, Andy Fox3. 1. Pharmacy Department, University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK. Priya.mistry5@nhs.net. 2. Gastroenterology Department, University Hospital Southampton NHS Foundation Trust, Southampton, UK. 3. Pharmacy Department, University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK.
Abstract
INTRODUCTION: There is limited comprehensive literature focussing on the range of patient safety incidents related to parenteral nutrition (PN). OBJECTIVE: The aim of this review was to examine patient safety incidents related to the use of PN in all patient age groups. METHODS: Literature published in the English language between January 2000 and April 2020 were searched across the MEDLINE, CINHAL and Embase databases. Articles were included if they contained PN-related patient safety incidents related to an avoidable event. No restrictions were applied to patient populations. The screening process was undertaken independently by two authors. RESULTS: In total, 108 records were included in the review: 52 case studies, 54 observation studies (e.g. prevalence studies, surveys) and two experimental studies. All age groups were represented, with 62% of studies in paediatrics (of which two-thirds were neonates) and 23% in adults. They included all medication processes: prescribing, dispensing, compounding, administration and monitoring. Incidents were related to microbial contamination, venous access and specific components (e.g. lipid emulsion, amino acids, glucose, micronutrients and electrolytes) or the whole product. Incident outcomes ranging from near miss to death were reported. Intervention studies looked at the impact on patient safety incidents of computerised tools, healthcare processes, e.g. pharmacist screening, and standardisation. One study demonstrated more severe outcomes with paediatric than with adult PN. CONCLUSIONS: This review demonstrates the vast range of PN-related patient safety incidents in all patient age groups and all medication process stages. The need for a national study looking at patient safety incidents related to PN in England is highlighted.
INTRODUCTION: There is limited comprehensive literature focussing on the range of patient safety incidents related to parenteral nutrition (PN). OBJECTIVE: The aim of this review was to examine patient safety incidents related to the use of PN in all patient age groups. METHODS: Literature published in the English language between January 2000 and April 2020 were searched across the MEDLINE, CINHAL and Embase databases. Articles were included if they contained PN-related patient safety incidents related to an avoidable event. No restrictions were applied to patient populations. The screening process was undertaken independently by two authors. RESULTS: In total, 108 records were included in the review: 52 case studies, 54 observation studies (e.g. prevalence studies, surveys) and two experimental studies. All age groups were represented, with 62% of studies in paediatrics (of which two-thirds were neonates) and 23% in adults. They included all medication processes: prescribing, dispensing, compounding, administration and monitoring. Incidents were related to microbial contamination, venous access and specific components (e.g. lipid emulsion, amino acids, glucose, micronutrients and electrolytes) or the whole product. Incident outcomes ranging from near miss to death were reported. Intervention studies looked at the impact on patient safety incidents of computerised tools, healthcare processes, e.g. pharmacist screening, and standardisation. One study demonstrated more severe outcomes with paediatric than with adult PN. CONCLUSIONS: This review demonstrates the vast range of PN-related patient safety incidents in all patient age groups and all medication process stages. The need for a national study looking at patient safety incidents related to PN in England is highlighted.
Authors: H Habsah; M Zeehaida; H Van Rostenberghe; R Noraida; W I Wan Pauzi; I Fatimah; A R Rosliza; N Y Nik Sharimah; H Maimunah Journal: J Hosp Infect Date: 2005-11 Impact factor: 3.926
Authors: Helena C Maltezou; Kyriaki Tryfinopoulou; Panos Katerelos; Lemonia Ftika; Olga Pappa; Maria Tseroni; Evangelos Kostis; Christos Kostalos; Helen Prifti; Konstantina Tzanetou; Alkiviadis Vatopoulos Journal: Am J Infect Control Date: 2012-01-20 Impact factor: 2.918
Authors: A T Tresoldi; M C Padoveze; P Trabasso; J F Veiga; S T Marba; A von Nowakonski; M L Branchini Journal: Am J Infect Control Date: 2000-06 Impact factor: 2.918